An association between bone mineral density and anabolic hormones in middle-aged and elderly men with prediabetes

References

• Jiang HX, Majumdar SR, Dick DA, et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res. 2005;20:494–500.
   PubMed Web of Science ®Google Scholar
• Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev. 2006;29:441–464.
   Web of Science ®Google Scholar
• Finkelstein JS, Klibanski A, Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab. 1996;81:1152–1155.
   PubMed Web of Science ®Google Scholar
• Lipscombe LL, Jamal SA, Booth GL, et al. The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care. 2007;30:835–841.
   PubMed Web of Science ®Google Scholar
• Ahmed LA, Joakimsen RM, Berntsen GK, et al. Diabetes mellitus and the risk of nonvertebral fractures: the Tromsø study. Osteoporos Int. 2006;17:495–500.
   PubMed Web of Science ®Google Scholar
• Lunt M, Masaryk P, Scheidt-Nave C. The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int. 2001;12:688–698.
   PubMed Web of Science ®Google Scholar
• Thrailkill KM, Lumpkin CK, Jr, Bunn RC, et al. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab. 2005;289:E735–E745.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81–S90.
   PubMed Web of Science ®Google Scholar
• Cho NH, Whiting D, Guariguata L. IDF. Diabetes Atlas. 6th ed. International Diabetes Federation; 2013; p. 39–49.
   Google Scholar
• Rhee SY, Woo JT. The prediabetic period: review of clinical aspects. Diabetes Metab J. 2011;35:107–116.
   PubMedGoogle Scholar
• Rochira V, Balestrieri A, Madeo A, et al. Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology. Eur J Endocrinol. 2006;154:175–185.
   PubMed Web of Science ®Google Scholar
• Vanderschueren D, Vandenput L, Boonen S, et al. Androgens and bone. Endocr Rev. 2004;25:389–425.
   PubMed Web of Science ®Google Scholar
• Vasilkova O, Mokhort T, Sanec I, et al. Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus. Clin Chem Lab Med. 2011;49:99–103.
   PubMed Web of Science ®Google Scholar
• Rabijewski M, Papierska L, Piątkiewicz P. Late-onset hypogonadism among old and middle-aged males with prediabetes in Polish population. Aging Male. 2015;8:16–21.
   Web of Science ®Google Scholar
• Lee JH, Lee YH, Jung KH, et al. Bone mineral density in prediabetic men. Korean Diabetes J. 2010;34:294–302.
   PubMedGoogle Scholar
• Athyros GV, Ganotakis ES, Elisaf M, et al. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin. 2005;21:1157–1164.
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666–3672.
   PubMed Web of Science ®Google Scholar
• Rabijewski M, Papierska L, Kuczerowski R, et al. Hormonal determinants of the severity of andropausal and depressive symptoms in middle-aged and elderly men with prediabetes. Clin Interv Aging. 2015;10:1381–1391.
   PubMed Web of Science ®Google Scholar
• Rabijewski M, Papierska L, Kuczerowski R, et al. Hormonal determinants of erectile dysfunction and lower urinary tract symptoms in middle-aged and elderly men with prediabetes. Aging Male. 2015;18:256–264.
   PubMed Web of Science ®Google Scholar
• Bellido T, Jilka RL, Boyce BF, et al. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest. 1995;95:2886–2895.
   PubMed Web of Science ®Google Scholar
• Szulc P, Munoz F, Claustrat B, et al. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab. 2001;86:192–199.
   PubMed Web of Science ®Google Scholar
• Araujo AB, O’Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older man: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89:5925–5926.
   Web of Science ®Google Scholar
• Amin S, Zhang Y, Sawin CT, et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med. 2000;133:951–963.
   PubMed Web of Science ®Google Scholar
• Bjornerem A, Emaus N, Berntsen GK, et al. Circulating sex steroids, sex hormone-binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausal women and men: the Tromso study. Calcif Tissue Int. 2007;81:65–72.
   PubMed Web of Science ®Google Scholar
• Kayath MJ, Dib SA, Vieira JG. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabetes Complications. 1994;97: 97–104.
   Google Scholar
• Ogata N, Chikazu D, Kubota N. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest. 2000;105:935–943.
   PubMed Web of Science ®Google Scholar
• Fulzele K, Riddle RC, Cao X. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142:309–319.
   PubMed Web of Science ®Google Scholar
• Thomas DM, Udagawa N, Hards DK. Insulin receptor expression in primary and cultured osteoclast-like cells. Bone. 1998;23:181–186.
   PubMed Web of Science ®Google Scholar
• Birkeland KI, Hanssen KF, Torjesen PA, et al. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab. 1993;76:275–278.
   PubMed Web of Science ®Google Scholar
• Conover CA, Lee PDK, Riggs BL, et al. Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology. 1996;137:3295–3301.
   PubMed Web of Science ®Google Scholar
• Grossmann M, Thomas MC, Panagiotopoulos S, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008;93:1834–1840.
   PubMed Web of Science ®Google Scholar
• Selvin E, Feinleib M, Zhang L, et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care. 2007;30:234–238.
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015;18:5–15.
   PubMed Web of Science ®Google Scholar
• Katznelson L, Finkelstein J, Schoenfeld D et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996;81: 4358–4365.
   PubMed Web of Science ®Google Scholar
• Wang C, Swerdloff RS, Iranmanes A, et al. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf). 2001;54:739–750.
   PubMed Web of Science ®Google Scholar
• Jones TH, Arver S, Behre HM, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care. 2011;34:828–837.
   PubMed Web of Science ®Google Scholar
• Haider A, Yassin A, Doros G, et al. Effects of long-term testosterone therapy on patients with “diabesity”: results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes. Int J Endocrinol. 2014:683515.
   PubMed Web of Science ®Google Scholar
• Saukkonen T, Cederberg H, Jokelainen J, et al. Limited overlap between intermediate hyperglycemia as defined by A1C 5.7–6.4%, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care. 2011;34:2314–2316.
   PubMed Web of Science ®Google Scholar